International Journal of Cardiology: Heart & Vasculature (Jun 2022)

Hypovitaminosis D and cardiovascular outcomes: A systematic review and meta-analysis

  • Vikash Jaiswal,
  • Angela Ishak,
  • Song Peng Ang,
  • Nishan Babu Pokhrel,
  • Nishat Shama,
  • Kriti Lnu,
  • Jeffy Susan Varghese,
  • Tatyana Storozhenko,
  • Jia Ee Chia,
  • Sidra Naz,
  • Prachi Sharma,
  • Akash Jaiswal

Journal volume & issue
Vol. 40
p. 101019

Abstract

Read online

Background: The relation between blood vitamin D levels and the risk of cardiovascular outcomes is debatable. To our knowledge this is the first comparative meta-analysis of more than 100,000 patients’ data with the aim to inspect the relevance of low vitamin D levels with adverse cardiovascular events. Methods: Online databases including PubMed, Embase and Cochrane Central were queried to compare the cardiovascular outcomes among hypovitaminosis D (HVD) and control group. The outcomes assessed included differences in major adverse cardiovascular events (MACE), mortality, myocardial infarction, and heart failure. Unadjusted odds ratios (OR) were calculated using a random-effect model with a 95% confidence interval (CI) and P less than 0.05 as a statistical significance. Results: A total of 8 studies including 426,039 patients were included in this analysis. HVD group was associated with a higher incidence of MACE (OR 1.92, 95% CI 1.24 to 2.98, p = 0.003), while there was no significant association of HVD and all-cause mortality (OR 1.77, 95% CI 0.75 to 4.17, p = 0.19), risk of myocardial infarction (OR 0.69, 95% CI 0.39 to 1.24, p = 0.22), and heart failure (OR 1.20, 95% CI 0.34 to 4.25, p = 0.78). Conclusions: This meta-analysis suggested that low blood levels of vitamin D are associated with MACE, but no such difference in all-cause mortality, myocardial infarction or heart failure was observed. Appropriate supplementation of vitamin D in selected populations might be cardioprotective in nature and warrants extensive trials.

Keywords